We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Q&A: Transplant therapy for diabetes exhibits promising outcomes
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Q&A: Transplant therapy for diabetes exhibits promising outcomes
Q&A: Transplant therapy for diabetes exhibits promising outcomes
Health

Q&A: Transplant therapy for diabetes exhibits promising outcomes

Last updated: January 19, 2025 3:59 am
Editorial Board Published January 19, 2025
Share
SHARE

Per-Ola Carlsson, Professor of Medical Cell Biology. Credit score: Mikael Wallerstedt

A totally new manner of treating sort 1 diabetes is being examined at Uppsala College Hospital. Sufferers are being supplied transplants of genetically modified insulin-producing cells and the preliminary outcomes are promising. We put a couple of inquiries to Per-Ola Carlsson, Professor of Medical Cell Biology, who’s main the research.

The research began in December and has already attracted a number of consideration. What makes it so particular?

To discover a healing therapy for diabetes, two elements are wanted. Firstly, it’s important to have a adequate amount of insulin-producing cells to have the ability to deal with many people with sort 1 diabetes. This drawback has truly been solved within the final ten years via a sort of stem cell therapy with insulin-producing cells that’s at the moment present process medical trials.

The remaining drawback has been that because the cells come from one other particular person, the sufferers want lifelong immunosuppressive therapy, which might result in critical side-effects. What now we have completed is to see whether or not we will discover a risk and a technique for transplanting cells between people with out immunosuppressive medication.

You have got developed genetically modified insulin-producing cells which might be hypoimmune, in order that immunosuppressive therapy shouldn’t be required. For the primary time, they’ve been transplanted right into a human. How has it gone?

We need to see if we will transplant between people and get the cells to outlive. Although this research is primarily a security trial, after all we’re taking the chance to see how the cells are doing.

On the finish of the yr, we had simply over 4 weeks of observations and noticed that the same amount of cells remained as once we inserted them. They don’t disappear, they’ve stayed there with their very own steady insulin manufacturing over the course of those weeks. What we might in any other case have anticipated in a transplant between people is that we might have had a rejection course of and would have already got misplaced this cell perform within the first few weeks.

What would be the subsequent stage of your analysis?

We’ll now proceed to watch this over time. Such a research has to hold on for 15 years to indicate that the therapy is secure. It could not take that lengthy to have the ability to say that the cells work and that it is fairly secure, so we cannot wait all that point earlier than we go forward with new research.

The subsequent step is to use this genetic modification to stem cells. That may make it potential to provide large portions of insulin-producing cells with this genetic modification. We might then have a lot of cells that might be utilized in medical trials and may be made right into a pharmaceutical product.

Transplantation therapy for diabetes

For individuals with extreme sort 1 diabetes, transplantation of islets of Langerhans containing insulin-producing cells has been a longtime therapy for over 20 years.
These cells come from the pancreas of a deceased donor and are transplanted right into a affected person with the intention of reaching regular blood sugar management and insulin independence.
As with all different organ and cell transplants, suppression of the recipients immune system has up to now been required to forestall immune rejection of the transplanted cells.
The insulin-producing cells used within the new research are genetically modified to keep away from detection by the immune system, which protects them from each rejection and autoimmune assault.

Offered by
Uppsala College

Quotation:
Q&A: Transplant therapy for diabetes exhibits promising outcomes (2025, January 17)
retrieved 18 January 2025
from https://medicalxpress.com/information/2025-01-qa-transplant-treatment-diabetes-results.html

This doc is topic to copyright. Other than any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for info functions solely.

You Might Also Like

Psilocybin may reverse results of mind accidents ensuing from intimate associate violence, rat research finds

Predicting illness outbreaks utilizing social media

Deep mind stimulation succeeds for 1 in 2 sufferers with treatment-resistant extreme melancholy and nervousness in trial

Australian drug driving deaths have surpassed drunk driving. Here is the way to deal with it

Tooth of infants of confused moms come out earlier, suggests examine

TAGGED:Diabetespromisingresultsshowstransplanttreatment
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Winter Conferences primer: Yankees have a lot of wants as they wait on Juan Soto
Sports

Winter Conferences primer: Yankees have a lot of wants as they wait on Juan Soto

Editorial Board December 5, 2024
Isaac Julien Returns to the Chopping Room Ground of Historical past
Studying to see after being born blind: Mind imaging research highlights toddler adaptability
UK’ M&S debuts Autograph Efficiency menswear for contemporary residing
HP unveils a spread of AI desktops and laptops at AMD/Intel occasions at CES

You Might Also Like

New malaria drug heralds resistance breakthrough
Health

New malaria drug heralds resistance breakthrough

November 18, 2025
Chasing a successful streak: A brand new approach to set off responses within the physique by simulating psychological strain
Health

Chasing a successful streak: A brand new approach to set off responses within the physique by simulating psychological strain

November 18, 2025
The worldwide system for assessing organ dysfunction in critically sick sufferers is up to date after thirty years
Health

The worldwide system for assessing organ dysfunction in critically sick sufferers is up to date after thirty years

November 18, 2025
Breast most cancers remedies can enhance each survival probabilities and revenue
Health

Breast most cancers remedies can enhance each survival probabilities and revenue

November 18, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • Art
  • World

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?